Finally, hope for a young patient with CGD

September 14, 2016


At 16, Brenden was so sick that he started planning his funeral, Harvard Gazette reports. Today, Brenden, who has a rare immune disorder called chronic granulomatous disease (CGD), is 23 years old, back working at a golf course and preparing, with cautious optimism, to return to college. What changed? He participated in a gene therapy clinical trial to correct a disease that severely weakens the infection-fighting abilities. “I had been so sick last year, I was willing to do anything not to be that sick anymore,” Brenden tells the Gazette.

Media Inquiries

Irene Sege
Senior Media Relations Specialist

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo